| Not Yet Recruiting | Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotin Vaping Cessation | Phase 3 | 2026-05-15 |
| Completed | Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers Smoking Cessation, Vaping Cessation | Phase 3 | 2024-05-28 |
| Completed | Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multipl Smoking Cessation | Phase 1 | 2023-08-08 |
| Completed | Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 Renal Impairment | Phase 1 | 2023-01-10 |
| Completed | Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Hea Smoking Cessation | Phase 1 | 2022-10-17 |
| Completed | A Study of Cytisinicline for Vaping Cessation in Adult Smokers Vaping, E-Cig Use | Phase 2 | 2022-07-13 |
| Completed | A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers Smoking Cessation | Phase 3 | 2022-01-20 |
| Completed | A Study of Cytisinicline for Smoking Cessation in Adult Smokers Smoking Cessation | Phase 3 | 2020-10-13 |
| Completed | A Single Dose-escalation Study of Cytisine in Adult Smokers Smoking Cessation | Phase 1 | 2019-02-28 |
| Completed | Trial of Cytisine in Adult Smokers Smoking Cessation | Phase 2 | 2018-11-13 |
| Completed | A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formu Smoking Cessation | Phase 1 | 2018-04-27 |
| Terminated | A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers Smoking Cessation | Phase 1 / Phase 2 | 2017-10-06 |
| Completed | A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine Smoking Cessation | Phase 1 | 2017-08-08 |
| Completed | Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization Cardiac Conduction and Repolarization | Phase 1 | 2013-05-01 |
| Completed | A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer | Phase 3 | 2012-10-24 |
| Completed | Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prost Prostate Cancer | Phase 3 | 2012-08-01 |
| Completed | A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of t Cancer | Phase 1 | 2012-04-01 |
| Completed | A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms | Phase 2 | 2011-10-01 |
| Completed | Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Ca Prostate Cancer | Phase 3 | 2010-11-01 |
| Terminated | A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Castrate-Resistant Prostate Cancer, Hormone Refractory Prostate Cancer | Phase 3 | 2010-03-01 |
| Completed | Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer Neoplasms | Phase 1 | 2007-06-01 |
| Completed | Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors Breast Neoplasms, Colorectal Neoplasms, Pancreatic Neoplasms | Phase 1 | 2006-09-01 |
| Completed | Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRP Prostate Cancer | Phase 2 | 2006-07-01 |
| Terminated | Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Breast Neoplasm | Phase 3 | 2005-09-01 |
| Completed | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2004-11-01 |
| Completed | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer Breast Cancer | Phase 2 | 2004-10-01 |
| Completed | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Uroth Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms | Phase 2 | 2003-11-01 |
| Completed | Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 2 | 2002-04-01 |
| Completed | Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium Urologic Neoplasms | Phase 2 | 2002-04-01 |
| Completed | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer Ovarian Cancer | Phase 2 | 2002-03-01 |
| Completed | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma Colorectal Adenocarcinoma | Phase 2 | 2002-03-01 |